Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 381-393

  Tezel, Ahmet ^a   Sens, Ashley ^b   Mitragotri, Samir ^a  

^a University of California at Santa Barbara   (United States)

^b Santa Barbara City College   (United States)

Author keywords

Permeability; Porosity; Porous pathway; Skin; Sonophoresis; Tortuosity

Indexed keywords

DEXTRAN; GONADORELIN; INULIN; MANNITOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ECHOGRAPHY; HYDROPHILICITY; LOW FREQUENCY SONOPHORESIS; NONHUMAN; POROSITY; SKIN PERMEABILITY; SOLUTE; SWINE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 12244310451     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10299     Document Type: Article

References (33)

1. Simon GA, Maibach HI. 2000. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol 13:229-234.
2. Elias PM. 1983. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80:44-49.
3. Suhonen TM, Bouwstra JA, Urtti A. 1999. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alteration. J Controlled Release 59:149-161.
4. Forslind B, Engstrom S, Engblom J, Norlen L. 1997. A novel approach to the understanding of human barrier function. J Dermatol Sci 14:115-125.
5. Walters KA, Hadgraft J. 1993. Pharmaceutical skin penetration enhancement. vol. 59: New York: Marcel Dekker.
6. Kalia YN, Guy RH. 1997. Interaction between penetration enhancers and iontophoresis: Effect on human skin impedance in vivo. J Controlled Release 44:33-42.
7. Prausnitz MR, Bose V, Langer R, Weaver JC. 1993. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504-10508.
8. Levy D, Kost J, Meshulam Y, Langer R. 1989. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest 83:2974-2978.
9. Mitragotri S, Blankschtein D, Langer R. 1996. Transdermal drug delivery using low frequency sonophoresis. Pharm Res 13:411-420.
10. Mitragotri S, Blankschtein D, Langer R. 1995. Ultrasound-mediated transdermal protein delivery. Science 269:850-853.
11. Tang H, Mitragotri S, Blankschtein D, Langer R. 2001. Theoretical description of transdermal transport of hydrophilic permeants: Application to low-frequency sonophoresis. J Pharm Sci 90:545-568.
12. Tezel A, Sens A, Mitragotri S. 2002. A theoretical analysis of low-frequency sonophoresis: Dependence of transdermal transport pathways on frequency and energy density. Pharm Res 19:1843-1848.
13. Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm Res 9:663-669.
14. Peck KD, Ghanem AH, Higuchi WI. 1994. Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm Res 11:1306-1314.
15. Lai P, Roberts MS. 1999. An analysis of solute structure human epidermal transport relationships in epidermal iontophoresis using the ionic mobility: Pore model. J Controlled Release 58:323-333.
16. Lai P, Roberts MS. 1998. Epidermal iontophoresis: II. Application of the ionic mobility-pore model to the transport of local anesthetics. Pharm Res 15: 1579-1588.
17. Yoshida NH, Roberts MS. 1993. Solute molecular size and transdermal iontophoresis across excised human skin. J Controlled Release 25:177-195.
18. Dinh S, Luo C, Berner B. 1993. Upper and lower limits of human skin electrical resistance in iontophoresis. AIChE J 39:2011-2018.
19. Ruddy S, Hadzija B. 1992. Iontophoretic permeability of polyethylene glycols through hairless rat skin: Application of hydrodynamic theory for hindered transport through liquid filled pores. Drug Design Discovery 8:207-224.
20. Franz TJ, Tojo K, Shah KR, Kydonieus A. 1992. Transdermal delivery. In: Kydonieus A, editor. Treatise on controlled delivery. New York: Marcel Dekker. pp. 341-422.
21. Cornwell PA, Barry BW. 1993. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int J Pharm 94:189-194.
22. Menon GK, Elias PM. 1997. Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 10(5-6):235-246.
23. Costigan SC, Booth PJ, Templer RH. 2000. Estimations of lipid bilayer geometry in fluid lamellar phases. Biochim Biophys Acta 1468:41-54.
24. Cevc G, Richardsen H. 1999. Lipid vesicles and membrane fusion. Adv Drug Deliv Rev 38:207-232.
25. Raphael RM, Waugh RE, Svetina S, Zeks B. 2001. Fractional occurrence of defects in membranes and mechanically driven interleaflet phopholipid transport. Phys Rev B 64(5), art. no 05913, part 1.
26. Malghani MS, Yang J, Wu J. 1998. Generation and growth of bilayer defects induced by ultrasound. J Acoust Soc Am 103:1682-1685.
27. Sznitowska M, Janicki S, Williams AC. 1998. Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. J Pharm Sci 87:1109-1114.
28. Deen WM. 1987. Hindered transport of large molecules in liquid-filled pores. AIChE 33:1409-1424.
29. Phillips RJ, Deen WM, Brady JF. 1989. Hindered transport of spherical macromolecules in fibrous membranes and gels. AIChE 35:1761-1769.
30. Tezel A, Sens A, Tuchscherer J, Mitragotri S. 2002. Synergistic effect of low frequency ultrasound and surfactants on skin permeability. J Pharm Sci 91: 91-100.
31. Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J, Blankschtein D, Langer R. 2000. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci 89:892-900.
32. Hunt AG. 2000. Applications of percolation theory to porous media with distributed local conductances. Adv Water Resource 24:279-307.
33. Xiang TX. 1993. A computer simulation of freevolume distributions and related structural properties in a model bilayer. Biophys J 65:1108-1120.